Illumine Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,540
Closed -$414K 80
2026
Q1
$426K Hold
3,540
0.33% 81
2025
Q4
$373K Hold
3,540
0.27% 82
2025
Q3
$297K Sell
3,540
-100
-3% -$8.24K 0.21% 84
2025
Q2
$288K Buy
3,640
+700
+24% +$55.6K 0.23% 81
2025
Q1
$264K Hold
2,940
0.22% 85
2024
Q4
$292K Buy
+2,940
New +$303K 0.24% 80

Other funds holding MRK

Illumine Investment Management's MRK Position: Q2 2026 in Review

Illumine Investment Management sold out of Merck (MRK) in Q2 2026, closing a stake of 3,540 shares — an estimated $414K sold.

Illumine Investment Management first reported a position in MRK in Q4 2024 and held it in 6 quarters. The position peaked at $426K in Q1 2026. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Illumine Investment Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Illumine Investment Management sold 3,540 Merck shares in Q2 2026, an estimated $414K.
  • Illumine Investment Management first reported a position in Merck in Q4 2024 and held it in 6 quarters.
  • Illumine Investment Management's Merck position peaked at $426K in Q1 2026.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Illumine Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.